These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 29215423)

  • 1. GALT Deficiency Galactosemia.
    Anderson S
    MCN Am J Matern Child Nurs; 2018; 43(1):44-51. PubMed ID: 29215423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactosemia: when is it a newborn screening emergency?
    Berry GT
    Mol Genet Metab; 2012 May; 106(1):7-11. PubMed ID: 22483615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of inherited disorders of galactose metabolism.
    Cuthbert C; Klapper H; Elsas L
    Curr Protoc Hum Genet; 2008 Jan; Chapter 17():Unit 17.5. PubMed ID: 18428423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare cases of galactose metabolic disorders: identification of more than two mutations per patient.
    Schulpis KH; Thodi G; Chatzidaki M; Iakovou K; Molou E; Dotsikas Y; Loukas YL
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1119-1120. PubMed ID: 28902631
    [No Abstract]   [Full Text] [Related]  

  • 5. The Importance of Neonatal Screening for Galactosemia.
    Badiu Tișa I; Achim AC; Cozma-Petruț A
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary galactosemia.
    Demirbas D; Coelho AI; Rubio-Gozalbo ME; Berry GT
    Metabolism; 2018 Jun; 83():188-196. PubMed ID: 29409891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of galactose-1-phosphate measurement enhances newborn screening for classical galactosemia.
    Daas S; Abu Salah N; Anikster Y; Barel O; Damseh NS; Dumin E; Fattal-Valevski A; Falik-Zaccai TC; Habib C; Josefsberg S; Korman SH; Kneller K; Landau Y; Lerman-Sagie T; Mandel H; Manor Y; Moady Abdalla T; Rock R; Rostami N; Saada A; Saraf-Levy T; Shaul Lotan N; Spiegel R; Staretz-Chacham O; Tal G; Ulanovsky I; Vaisid T; Wilnai Y; Almashanu S
    J Inherit Metab Dis; 2023 Mar; 46(2):232-242. PubMed ID: 36515074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for galactosemia: a review of 5 years of data and audit of a revised reporting approach.
    Freer DE; Ficicioglu C; Finegold D
    Clin Chem; 2010 Mar; 56(3):437-44. PubMed ID: 20075179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Florida newborn screening for galactosemia.
    DeClue TJ; Malone JI; Tedesco TA
    J Fla Med Assoc; 1991 Jun; 78(6):369-71. PubMed ID: 1831492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for galactosemia: Philippines experience. Newborn Screening Study Group.
    Lee JY; Padilla CD; Chua EL
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():66-8. PubMed ID: 11405207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous occurrence of various mutations and polymorphisms in cis and in trans of the galactose-1-phosphate uridyltransferase gene in a Turkish family with classical galactosemia.
    Schuster V; Podskarbi T; Ottensmeier H; Haubner M; Shin YS
    J Mol Med (Berl); 1998 Sep; 76(10):715-9. PubMed ID: 9766850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nine years of newborn screening for classical galactosemia in the Netherlands: Effectiveness of screening methods, and identification of patients with previously unreported phenotypes.
    Welling L; Boelen A; Derks TG; Schielen PC; de Vries M; Williams M; Wijburg FA; Bosch AM
    Mol Genet Metab; 2017 Mar; 120(3):223-228. PubMed ID: 28065439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial deficiency of galactose-1-phosphate uridyltransferase.
    Gitzelmann R; Bosshard NU
    Eur J Pediatr; 1995; 154(7 Suppl 2):S40-4. PubMed ID: 7671963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Galactose-1-phosphate uridyltransferase deficiency].
    Okano Y; Isshiki G
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):15-21. PubMed ID: 9589977
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and molecular spectra in galactosemic patients from neonatal screening in northeastern Italy: structural and functional characterization of new variations in the galactose-1-phosphate uridyltransferase (GALT) gene.
    Viggiano E; Marabotti A; Burlina AP; Cazzorla C; D'Apice MR; Giordano L; Fasan I; Novelli G; Facchiano A; Burlina AB
    Gene; 2015 Apr; 559(2):112-8. PubMed ID: 25592817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of an LC-MS/MS-based erythrocyte GALT enzyme assay to predict the phenotype in subjects with GALT deficiency.
    Demirbas D; Huang X; Daesety V; Feenstra S; Haskovic M; Qi W; Gubbels CS; Hecht L; Levy HL; Waisbren SE; Berry GT
    Mol Genet Metab; 2019 Apr; 126(4):368-376. PubMed ID: 30718057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex tandem mass spectrometry assay for newborn screening of X-linked adrenoleukodystrophy, biotinidase deficiency, and galactosemia with flexibility to assay other enzyme assays and biomarkers.
    Hong X; Kumar AB; Ronald Scott C; Gelb MH
    Mol Genet Metab; 2018 Jun; 124(2):101-108. PubMed ID: 29680633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile and molecular characterization of Galactosemia in Brazil: identification of seven novel mutations.
    Garcia DF; Camelo JS; Molfetta GA; Turcato M; Souza CF; Porta G; Steiner CE; Silva WA
    BMC Med Genet; 2016 May; 17(1):39. PubMed ID: 27176039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the molecular nature of the Duarte variant of galactose-1-phosphate uridyl transferase (GALT).
    Lin HC; Kirby LT; Ng WG; Reichardt JK
    Hum Genet; 1994 Feb; 93(2):167-9. PubMed ID: 8112740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective screening for neonatal galactosemia: an alternative approach.
    Shah V; Friedman S; Moore AM; Platt BA; Feigenbaum AS
    Acta Paediatr; 2001 Aug; 90(8):948-9. PubMed ID: 11529548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.